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Background: Mice and humans produce chitinase-like proteins (CLPs), which are highly homologous to chitinases
but lack chitinolytic activity. Mice express primarily three CLPs, including breast regression protein-39 (BRP-39)
[chitinase 3-like-1 (Chi3l1) or 38-kDa glycoprotein (gp38k)], Ym1 (Chi3l3) and Ym2 (Chi3l4). Recently, CLPs have
attracted considerable attention due to their increased expression in a number of pathological conditions,
including asthma, allergies, rheumatoid arthritis and malignant tumors. Although the exact functions of CLPs are
largely unknown, the significance of their increased expression levels during pathophysiological states needs to be
determined. The quantification of BRP-39, Ym1 and Ym2 is an important step in gaining insight into the in vivo
regulation of the CLPs.
Methods: We constructed a standard DNA for quantitative real-time PCR (qPCR) by containing three CLPs target
fragments and five reference genes cDNA in a one-to-one ratio. We evaluated this system by analyzing the eight
target cDNA sequences. Tissue cDNAs obtained by reverse transcription from total RNA from four embryonic stages
and eight adult tissues were analyzed using the qPCR system with the standard DNA.
Results: We established a qPCR system detecting CLPs and comparing their expression levels with those of five
reference genes using the same scale in mouse tissues. We found that BRP-39 and Ym1 were abundant in the
mouse lung, whereas Ym2 mRNA was abundant in the stomach, followed by lung. The expression levels of
BRP-39 and Ym1 in the mouse lung were higher than those of two active chitinases and were comparable to
glyceraldehyde-3-phosphate dehydrogenase, a housekeeping gene which is constitutively expressed in all tissues.
Conclusion: Our results indicate that catalytically inactive BRP-39 and Ym1 are constitutive genes in normal
mouse lung.
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Chitinase-like proteins (CLPs) are structurally homolo-
gous to chitinases but lack the ability to degrade chitin
[1,2]. Several CLPs have been identified in mice and
humans [3-14]. Mice express primarily breast regression
protein-39 (BRP-39) [chitinase 3-like-1 (Chi3l1) or 38-kDa
glycoprotein (gp38k)], Ym1 (Chi3l3) and Ym2 (Chi3l4),
whereas humans produce YKL-40 (CHI3L1 or human car-
tilage glycoprotein-39), the human homologue of BRP-39,
but do not synthesize Ym1 and Ym2 [3-10].
BRP-39 and YKL-40 are glycoproteins that are se-
creted by various cell types, including macrophages and
chondrocytes as well as tumor cells [3,10,15,16]. The
amino acid sequence of mouse BRP-39 shares 73%
identity with that of YKL-40 [15,16]. A recent study has
shown that BRP-39 and YKL-40 are functionally
equivalent [17]. Ym1 shows a high degree of sequence
homology to Ym2 with 91% amino acid sequence iden-
tity, but these proteins exhibit different expression pat-
terns [5,6,9].
Based on sequence similarities, CLPs belong to the fam-
ily 18 of the glycosyl hydrolases [1,2,18,19]. Family 18 of
the glycosyl hydrolases includes two catalytically active
mammalian chitinases, chitotriosidase (Chit1) and acidic
mammalian chitinase (AMCase) [20-23]. The conserved
sequence involved in catalysis in family 18 of the chitinases
is DXXDXDXE, where E is assumed to be the catalytic
residue [1,2,24]. It is generally assumed that the lack of
chitinase activity in CLPs is due to the mutation of crucial
residues within the conserved catalytic sequence during
evolution [1,2,24].
Increased levels of CLPs mRNAs and/or proteins have
been noted in many inflammatory conditions [2,17,25].
BRP-39/YKL-40 levels are increased in individuals with
asthma, chronic obstructive pulmonary disease (COPD),
cystic fibrosis, rheumatoid arthritis, inflammatory bowel
disease, alcoholic cirrhosis and different types of malig-
nant tumors [26-36]. Ym1 is synthesized during inflam-
mation caused by parasitic infections [37]. Ym1 and
Ym2 are expressed during allergic pulmonary inflamma-
tion [5]. Thus, CLPs may play important roles in many
pathophysiological conditions [38,39]. However, the con-
tribution of these proteins to the pathophysiology of
these diseases remains to be determined.
Recently we established quantitative real-time PCR
(qPCR) using a single standard DNA to quantify the ex-
pression levels of chitinases and reference genes [40,41].
This method enables us to quantify and compare the ex-
pression levels of multiple genes in the same scale. Be-
cause CLPs lack chitinolytic activity and detectable
functions, their biochemical properties have only been
partially defined [38]. The individual quantification of
BRP-39, Ym1 and Ym2 is an important step in gaining
insight into the in vivo regulation of the CLPs.In this study, we established qPCR system to quantify
the expression of BRP-39, Ym1 and Ym2 individually
and compared their expression levels to reference genes
using the same scale in mouse tissues. Our study shows
that the expression levels of BRP-39 and Ym1 in the
mouse lung are higher than those of two active chitinases
and are comparable to glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH), a housekeeping gene which is
constitutively expressed in all tissues to maintain cellular
functions [42-44].
Methods
RNA and cDNA preparation
The qPCR assay has been designed according to the
Minimum Information for Publication of Quantitative
Real-Time PCR Experiments (MIQE) guidelines [45,46].
We used two types of RNA samples in this research. One
is the commercially available total RNA samples pooled
from 200 ~ 1,200 mice (The Mouse Total RNA Master
Panel, Lot number 7120017, Clontech Laboratories). The
company tested rigorously the RNA integrity. We used the
total RNA samples to examine the distribution of the tran-
scripts in various mouse tissues. Moreover, we used total
RNA isolated from the lungs and stomachs of 3-month-old
male mice (n = 5). All animal procedures were conducted
according to the Guidelines for the Care and Use of
Laboratory Animals of the RIKEN and were approved by
the RIKEN Institutional Animal Care and Use Committee
(Approval No. H19-2B013). C57BL/6 J mice (CLEAR
Japan) were bred at the RIKEN Brain Science Institute
Animal Facility. Lung and stomach tissue samples for RNA
analysis were immediately frozen at −80°C. Those tissues
for mRNA preparation were provided by Drs. Miyazaki and
Nukina at RIKEN Brain Science Institute. Total RNA was
prepared from the tissues using TRIzol Reagent (Invitrogen)
according to the manufacturer’s instructions. To remove the
trace amounts of contaminating genomic DNA, the samples
were treated with RQ1 RNase-Free DNase (Promega)
according to the manufacturer’s recommended protocol.
The ratio of absorbance at 260 nm and 280 nm is used to
assess the purity of DNA and RNA. The ratio of each sam-
ple was ~2.0 using a BioPhotometer Plus (Eppendorf). The
concentrations of the nucleic acids were determined by
measuring the absorbance at 260 nm.
The total RNA samples (3 μg) were subjected to reverse
transcription using random hexamers. The reaction mix-
ture (15 μl) contained the enzyme buffer [50 mM Tris-
HCl (pH 8.3), 75 mM KCl, and 3 mM MgCl2], 100 ng of
random hexamers (Takara Bio), 10 mM dithiothreitol, and
0.5 mM deoxynucleotide triphosphates (dNTPs). After
heating the solution to 60°C for 5 min and incubating the
mixture at 37°C for 5 min, 200 U of recombinant murine
leukemia virus reverse transcriptase (Invitrogen) was
added, and the mixture was incubated at 37°C for 45 min.
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95°C for 5 min.
Selection of primer pairs for qPCR
Primers for qPCR were designed based on Primer Express
Software (Applied Biosystems) and were synthesized com-
mercially (Sigma-Genosys, Sigma-Aldrich). The PCR reac-
tions were performed in a final volume of 13 μl containing
2 x SYBR Green Master Mix (Brilliant II SYBR Green
QPCR Master Mix, Agilent), 2.7 ng of mouse cDNA or
appropriate dilutions of the external standards (see below),
and 2.5 pmol of the primers for the three CLPs. The PCR
reactions were performed using Mx3005P QPCR System
(Agilent). The PCR program was as follows: 10 min of
denaturation at 95°C, 40 cycles of denaturation at 95°C for
30 sec, annealing at 55°C for 1 min and polymerization at
72°C for 1 min. Melting curves were generated after amp-
lification. The PCR products were electrophoresed on a 10%
polyacrylamide gel and analyzed using the Luminescent
Image Analyzer (ImageQuant LAS 4000, GE Healthcare).
The nucleotide sequences of the primers that were used
for the qPCR are shown in Supplementary Information
(Additional file 1: Table S1). The Chit1, AMCase, pep-
sinogen C, GAPDH and β-actin primers have been pre-
viously reported [40].
Construction of the mouse Refs/CLPs standard DNA
The cDNA fragments covering the PCR-target region
plus 11–137 nucleotides of the flanking regions of BRP-
39, Ym1 and Ym2 were amplified from a mouse tissue
cDNA mixture by PCR. The forward and reverse
primers are listed in Additional file 1: Table S2. The
primers contained 6-bp long EcoRI, BglII or XhoI recog-
nition sites (shown in bold and italics) and 25-bp long
sequences corresponding to the nucleotides of each CLP
cDNA (Additional file 1: Table S2). These primers also
contain additional 4-bp extra nucleotides (underlined) to
ensure the efficient cleavage of the amplified cDNAs by
the restriction enzymes (Additional file 1: Table S2).
Each amplified DNA fragment contained restriction sites
anchored to the PCR primer sets. These PCR products
were purified using the Wizard SV Gel and PCR Clean-Up
System (Promega) and then digested with the appropriate
restriction enzymes, separated by 2% agarose gel electro-
phoresis and re-purified using the Clean-Up System. Each
fragment was then ligated using T4 DNA ligase (Promega).
The ligated fragments were PCR-amplified again using the
forward primer (EcoRI_Ym1_Fw) and the reverse primer
(Ym2_Rv) (Additional file 1: Table S2). The resulting frag-
ments were used as the CLPs standard DNA.
Construction of the five reference genes (Refs) and three
CLPs (Refs/CLPs) standard DNA for the mouse genes was
performed as previously described [40]. Briefly, mouse
Refs standard DNA consisting of AMCase/pepsinogen C/Chit1/GAPDH/β-actin and containing an EcoRI restric-
tion site at the 3’ terminus, was amplified from the stand-
ard DNA for mouse chitinase using PCR [41]. Both the
CLPs and the mouse Refs standard DNAs were digested
with EcoRI and ligated using T4 DNA ligase. The ligated
fragments were amplified using the forward primer
(Quant_mouse_AMCase_Fw) and the reverse primer
(Ym2_Rv) (Additional file 1: Table S2). The PCR product
was purified, and 3’-dA was added to the amplified DNA
using Takara Taq HS (Takara Bio) and the resulting frag-
ment was cloned into the pGEM-T Easy vector (Promega).
The plasmid containing the cDNA insert was sequenced
using the ABI PRISM Big-Dye Terminator v3.1 Cycle
Sequencing Kit and the 3130 Genetic Analyzer instrument
(Applied Biosystems). The mouse Refs/CLPs standard
DNA (1,597 nucleotides; see Figure 1A and Additional file
1: Figure S1) was prepared by PCR reamplification from
the plasmid DNA using the same primers; the PCR prod-
uct was purified as described above and was thereafter
used as the standard DNA.
The mouse Refs/CLPs standard DNA with pGEM-T
Easy vector (4,629 nucleotides; see Figure 2B and
Additional file 1: Figure S2) was prepared by PCR from
the plasmid DNA using the forward primer (BglII_BRP-
39_Fw) and the reverse primer (BglII_Ym1_Rv). The amp-
lified DNA was purified and subsequently used as the
mouse Refs/CLPs standard DNA with pGEM-T Easy.
Preparation of BRP-39, Ym1 and Ym2 cDNAs covering the
entire coding region
The cDNA covering the entire coding regions of BRP-39,
Ym1 and Ym2 were amplified from mouse lung (BRP-39
and Ym1) or stomach (Ym2) tissue cDNA by PCR using
primers (shown in Additional file 1: Table S3) and were
subcloned into the pcDNA3.1/V5-His C vector (Invitro-
gen). The cDNAs were sequence-verified (Additional file 1:
Figure S3). The subcloned fragments were reamplified from
the plasmid DNAs using the same primers (Additional
file 1: Table S3), and the resulting fragments were used as
the entire coding regions of the cDNAs.
Standard curves and mRNA quantification using qPCR
The molar concentration of the standard DNA was calcu-
lated based on the concentration and the molecular
weight. The concentrations of the nucleic acids were de-
termined by measuring the absorbance at 260 nm. The
molar concentration of the multigene-containing DNA
standard was calculated based on the concentration and
the molecular weight. Serial dilutions were prepared start-
ing with the standard template concentration, which
yielded a Ct of approximately 13 (Ct = fractional threshold
cycle value). The standard DNA was subjected to 10-fold
serial dilutions, ranging from 100 to 107 molecules, and
the aliquots were kept frozen at -20°C until use.














Figure 1 Construction and validation of the mouse Refs/CLPs standard DNA. (A) Schematic representation of the mouse Refs/CLPs standard
DNA used for qPCR analysis. We ligated the standard DNAs of the CLPs and the reference genes (Refs) DNA [40,41] using EcoRI restriction sites
and the resulting fragment was then cloned into the pGEM-T Easy vector. The linearized standard DNA was amplified from the plasmid DNA. To
examine whether the standard DNA gave one melting temperature, we amplified the mouse Refs/CLPs standard DNA using the Ym1 (B) and
Ym2 (C) primers. (D) The Ym1 and Ym2 PCR products were evaluated using 10% polyacrylamide gel analysis. (E) Multiple products were amplified




















: BglII_Ym1_RvThe mouse Refs/CLPs 
standard DNA in pGEM-T 
Easy
(4,615) 
Figure 2 Preparation and validation of the mouse Refs/CLPs standard DNA with pGEM-T Easy. (A) Schematic representation of the mouse
Refs/CLPs standard DNA cloning into pGEM-T Easy vector. (B) The mouse Refs/CLPs standard DNA with pGEM-T Easy was PCR-amplified from the
plasmid DNA using the BRP-39 forward (blue arrow) and Ym1 reverse (red arrow) primers. As described above, we amplified the Ym1 and Ym2
cDNAs from this standard DNA using the Ym1 (C) and Ym2 (D) primers and these PCR products were analyzed using 10% polyacrylamide gel
electrophoresis (E). The y axis was expressed as first derivative of the fluorescence as a function of temperature (C and D).
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naturation and polymerase activation step at 95°C for
10 min, 40 cycles of denaturation at 95°C for 30 sec, an-
nealing at 55°C for 30 sec and polymerization at 72°C
for 10 sec. The standard curves were constructed, and
mRNA quantification was performed. Each sample was
amplified in triplicate, and each experiment was repeated
at least two times.
Statistical analyses
Data are shown as mean with standard deviation (SD).
We used Student’s t test for mRNA-level analyses. Statistical
significance was set at p < 0.05.
Results
Establishment of a qPCR system for the detection of CLPs
in mouse tissues
First, we aimed to quantify the CLPs genes expression
levels across normal mouse tissues and to compare the
mRNA levels of CLPs and the mammalian chitinases and
reference genes (Figure 3).
We first established qPCR system that is capable of
determining the multiple mRNAs levels using the same
scale. We designed primer sets to analyze CLP expression
using quantitative PCR, as described in the Methods sec-
tion. Ym1 shared extensive nucleotide sequence homology
with Ym2, with an identity of 94% along the entire molecule
(Additional file 1: Figure S4) [9]. To prevent mispriming,
we designed reverse primers that were unique at the 3’
terminal region (Additional file 1: Figure S4 and Table S1).
However, because Ym1 and Ym2 share very high sequence
homology, we have to choose the forward primers highlyFigure 3 Strategy for comparing the gene expression levels of mouse
CLPs (BRP-39, Ym1 and Ym2) were quantified and compared. We then com
Chit1 and AMCase, and housekeeping genes.homologous between Ym1 and Ym2 (see Additional file 1:
Figure S4 and Table S1). We also designed BRP-39 specific
primers (Additional file 1: Table S1).
We evaluated primer suitability based on whether they
produced single products, as reflected by a single melting
temperature (Tm) and a single band on a 10% polyacryl-
amide gel. The PCR products were amplified from a
mouse tissue cDNA mixture. As shown in Figure 4A-C,
only single peaks appeared in the dissociation curves for
Ym1 (Tm = 76.3°C), Ym2 (Tm= 77.3°C) and BRP-39
(Tm= 80.8°C). Figure 4D shows clear single bands at the
expected sizes for the Ym1 (65 bp), Ym2 (65 bp) and BRP-
39 (57 bp) PCR fragments. These results indicate that the
PCR is specific producing single amplicons from the
mouse tissue cDNA mixture.Construction of the mouse Refs/CLPs standard DNA
We set up a qPCR system for which a standard DNA
was necessary for accurate quantification of three CLPs.
We used two chitinases and two housekeeping genes,
GAPDH and β-actin, along with pepsinogen C, as refer-
ence genes. To evaluate the CLP levels, we used GAPDH
and β-actin because they are constitutively expressed at
high levels in most tissues [42-44,47]. In addition, we
chose pepsinogen C (also known as progastricsin) as a
reference gene in the stomach. Pepsinogen C is an aspartic
protease that functions as a digestive enzyme and is pro-
duced in the stomach. This enzyme constitutes a major
component of the gastric mucosa [48]. Using these refer-
ence genes, we evaluated gene expression of three CLPs
and chitinases in mouse tissues.CLPs and chitinases. The expression levels of the mouse inactive
pared the expression levels of the CLPs and the active chitinases,
A. Ym1 B. Ym2

















Figure 4 Evaluation of the CLPs primers suitability for qPCR. The PCR primers were evaluated based on whether they gave one melting
temperature (A-C) and a single PCR product on a 10% polyacrylamide gel (D). The y axis was expressed as first derivative of the fluorescence
intensity as a function of temperature (A-C). To verify specificity, the dissociation curves of the PCR products for the three genes were generated
using a mouse tissue cDNA mixture. The PCR products were analyzed on a 10% polyacrylamide gel, followed by ethidium bromide staining (D).
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ence genes cDNA in a one-to-one ratio and then cloned
this DNA fragment into the pGEM-T Easy vector. The
1,597-nucleotide-long DNA contained five reference
genes (Refs) and three CLPs cDNA fragments that
spanned the PCR target regions and 9-146 nucleotides
of the flanking regions and contained several restriction
sites (Figure 1A and Additional file 1: Figure S1). We
name this molecule as the mouse Refs/CLPs standard
DNA in this report.
Evaluation of the mouse Refs/CLPs standard DNA with
pGEM-T Easy
Next, we examined whether the target cDNAs were
amplified from the mouse Refs/CLPs standard DNA
using the primer sets for the eight cDNAs. Although the
Ym1 primers gave a single product, as reflected by a single
melting temperature and a single band on a 10% polyacryl-
amide gel (Figure 1B and D), the Ym2 primers yielded three
peaks and multiple bands (Figure 1C and D). These results
indicated that multiple products were amplified from the
mouse Refs/CLPs standard DNA using the Ym2 primers.
To understand and overcome this problem, we com-
pared the nucleotide sequences of the standard DNA and
the Ym2 forward primer using the NCBI Blast Search (2
blast search) tool and found that the Ym2 forward primer
can anneal to Ym1 (Additional file 1: Figure S4) and can be
misprimed to the AMCase cDNAs. Ym1 and Ym2 did not
share any homology with BRP-39 and Chit1. Therefore, in
addition to the amplification of original Ym2 cDNA, twocDNAs (Ym1/BRP-39/Ym2 and AMCase/Pep C/Chit1/
GAPDH/β-actin/Ym1/ BRP-39/Ym2) can be amplified
from the standard DNA using the Ym2 primers (Figure 1C,
D and E). This problem could not be solved by the anneal-
ing temperature modification.
Many researchers have designed primers that span in-
trons or intron/exon boundaries for RT-PCR analysis [49].
We cloned the mouse Refs/CLPs standard DNA into the
pGEM-T Easy vector (Figure 2A). To increase the distance
between the AMCase/Ym1 and Ym2 fragments, we pre-
pared a linear standard DNA containing the pGEM-T
Easy sequence that contained BRP-39/Ym2/pGEM-T
Easy/AMCase/Pep C/Chit1/GAPDH/β-actin/Ym1 by PCR
using the BRP-39-forward (BglII_BRP-39_Fw) and Ym1
reverse (BglII_Ym1_Rv) primers (see Figure 2A and
Additional file 1: Figure S2 and Table S2). This standard
DNA is referred to as the mouse Refs/CLPs standard
DNA with pGEM-T Easy (Figure 2B).
We next examined whether the Ym2 primers only ampli-
fied Ym2 cDNA from this standard DNA. To avoid the
misprimed amplification, we shortened the annealing and
extension time in the qPCR program (55°C for 30 sec, 72°C
for 10 sec). After the PCR was performed, the Ym2 primers
yielded a single product, as reflected by a single melting
temperature (Figure 2D) and a single band on a 10%
polyacrylamide gel at the expected size for the Ym2 PCR
product (Figure 2E), as was case for the Ym1 products
(Figure 2C and E); these results indicated that a single
product was amplified from the mouse Refs/CLPs standard
DNA with pGEM-T Easy (Figure 2B and Additional file 1:
Ohno et al. BMC Molecular Biology 2014, 15:23 Page 7 of 12
http://www.biomedcentral.com/1471-2199/15/23Figure S2) using the Ym2 primer. Thus, the pGEM-T Easy
sequence (approximately ~3 kbp) worked as an intron se-
quence in the PCR reaction. Therefore, we used the mouse
Refs/CLPs standard DNA with pGEM-T Easy as the stand-
ard DNA unless otherwise specified.
Validation of the standard curve and the qPCR system
The quantification of the CLP, chitinase and the reference
mRNAs relies on standard curves. We next examined
whether the three CLPs and five reference genes mRNAs
were accurately quantified using this system. Serial dilu-
tions of the mouse Refs/CLPs standard DNA with pGEM-
T Easy (Figure 2B and Additional file 1: Figure S2) were
used to construct an individual standard curve to compare
and evaluate the qPCR quantification strategies that were
used to analyze the eight mRNAs. Each standard curve
was generated using 10-fold serial dilutions of theA. B.
D. E.
G. H.
Figure 5 Validation of a qPCR system for the analysis of mouse tissue
Ym2; (D), Chit1; (E), AMCase; (F), GAPDH; (G), β-actin; and (H), pepsinogen
DNA with pGEM-T Easy containing the eight mouse cDNA fragments (red
coding cDNA was performed using the primer pairs for each gene. The tar
with a known concentration and subsequently analyzed as an unknown sa
tested dilution of the standard curve and entire coding cDNA. Data are expstandard DNA and the eight different primer pairs,
yielding a dynamic range of seven orders of magnitude
(Figure 5A-H, red closed circles).
We next evaluated the qPCR quantification by analyzing
the eight cDNAs. To test the absolute equality of the
curves, known concentration of the entire coding cDNA
(Additional file 1: Figure S3) was amplified and subse-
quently analyzed as an unknown sample. As shown in
Figure 5A-H, blue closed rhombuses, equal quantities
were observed for each tested dilution used to construct
the standard curve. Thus, we could quantify the CLPs and
the reference mRNAs using the same scale.
Expression of CLPs in normal mouse tissues
To study the in vivo regulation of BRP-39, Ym1 and
Ym2 gene expression, tissue cDNAs reverse transcribed
from total RNA from four embryonic stages and eightC.
F.
: Mouse Cs/Refs/CLPs 
standard DNA with pGEM-T Easy
: Mouse entire coding cDNA
s. The analyzed cDNAs were the following: (A), BRP-39; (B), Ym1; (C),
C. Standard curves were obtained using the mouse Refs/CLPs standard
closed circles). In addition, the quantification of the mouse entire
get cDNA was amplified from a dilution of the entire coding cDNA
mple (blue closed rhombuses). Equal quantities were obtained for each
ressed as mean ± standard deviation (SD) of three measurements.
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Refs/CLPs standard DNA with pGEM-T Easy (Figure 2B
and Additional file 1: Figure S2). The BRP-39, Ym1 and
Ym2 mRNAs were widely expressed in the mouse tissues
(Figure 6A-C).
Clear tissue specificities were observed in the expres-
sion patterns of these CLPs mRNAs. BRP-39 mRNA
was also widely expressed in normal mouse tissues
(Figure 6A). The highest levels of BRP-39 mRNA were
detected in the lung, followed by the 7-day embryo,
eye, stomach and 17-day embryo (Figure 6A, upper and
lower panels).
Similarly, the highest levels of Ym1 mRNA were de-
tected in the mouse lung, followed by 7-day embryo
(Figure 6B, upper panel), whereas the highest levels of
Ym2 mRNA were detected in the mouse stomach,
followed by the lung (Figure 6C, upper panel). In other tis-
sues, the Ym1 and Ym2 mRNAs were expressed at low,
but easily detectable levels above background (Figure 6B
and C, lower panel). When compared to the levels of Ym2
mRNA, BRP-39 and Ym1 were synthesized at the higher
level in the lung tissue (Figure 6).B. YmA. BRP-39
Figure 6 BRP-39, Ym1 and Ym2 mRNA expression in mouse tissues. Q
tissues. The expression levels of the CLPs were quantified by real-time PCR
(the mouse Refs/CLPs standard DNA with pGEM-T Easy). The y axis was exp
the actual value, and the lower panel shows each value on logarithmic scaThe expression levels of CLP, chitinase and reference
gene mRNAs in mouse lung and stomach tissues
Many studies on the pathophysiology of CLPs and mam-
malian chitinases have been performed using lung tissue
[7,17,27,50-52]. In this study, we showed that Ym2 mRNA
is highly expressed in mouse stomach tissue (Figure 6).
Additionally, AMCase mRNA was overexpressed in
mouse stomach [23,40,41,53].
We next compared the expression levels of the CLPs
and reference genes using the lung and stomach tissue
cDNA as described in the Methods. Figure 7A shows the
results obtained from mouse lung tissue. Chit1 is a well-
characterized mammalian chitinase in lung tissues. When
the Chit1 levels were set at 1.0, the relative expression
levels of the cDNAs were 78 for BRP-39, 50 for Ym1, 0.3
for Ym2, 7.0 for AMCase, 81 for GAPDH and 292 for β-
actin in the mouse lung tissues (Figure 7A). The lung tis-
sues express higher levels of BRP-39 and Ym1 than Chit1
and AMCase, active mammalian chitinases (p < 0.01).
Furthermore, the expression levels of BRP-39 and Ym1
in the mouse lung tissues were comparable to the level
of GAPDH, a well-known housekeeping gene that isC. Ym21
uantification of BRP-39 (A), Ym1 (B) and Ym2 (C) mRNAs in mouse
using the standard DNA containing the eight mouse genes
ressed as molecules per 10 ng of total RNA. The upper panel indicates
le. Data are presented as mean ± SD of three measurements.
A. Lung B. Stomach
Figure 7 Analysis of BRP-39, Ym1 and Ym2 reference gene mRNAs in lung and stomach tissues. The expression levels of the eight genes
determined using the cDNAs prepared from lung (A) or stomach (B) tissues from 3-month-old mice (n = 5) were quantified by real-time PCR. All
of the values are expressed as number of molecules per 10 ng of total RNA in y axis. The upper panel indicates the actual value, and the lower
panel shows each value on logarithmic scale. The expression level of the mouse Chit1 gene was set to 1.0; the values above the bars indicate the
relative expression levels compared to the expression level of the mouse Chit1 gene. Data are presented as mean ± SD of five samples.
*p < 0.05; **p < 0.01.
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[42-44]. These results indicate that BRP-39 and Ym1 are
abundantly transcribed in the mouse lung.
Figure 7B shows the results obtained in the mouse
stomach tissues. When Chit1 levels were set to 1.0, the
relative expression levels of the cDNAs were 0.05 for
BRP-39, 0.03 for Ym1, 0.6 for Ym2, 473 for AMCase, 34
for GAPDH, 65 for β-actin and 1,443 for pepsinogen C
in the mouse stomach tissues (Figure 7B). The stomach
tissues express much lower levels of BRP-39 and Ym1
than Chit1 (p < 0.01). Although Ym2 mRNA was highly
expressed in the stomach, its expression was lower than
Chit1, an active mammalian chitinase (p < 0.05). Further-
more, the Ym2 expression level was much lower than
the levels of AMCase, GAPDH, β-actin and pepsinogen
C. These results indicate that Ym2 mRNA is abundant
in the stomach tissues.
Discussion
CLPs are structurally related to chitinases but lack chitino-
lytic activity [1,2,38]. CLPs levels are increased in a number
of serious pathological conditions. Thus, the biomedical
importance of CLPs has attracted considerable attention.
In this study, we established a quantitation method for
discriminating chitinase-like proteins and compared theirmRNA levels with those of the five reference genes. We
showed that catalytically inactive BRP-39 and Ym1 are
constitutive genes in mouse lung.
In our previous studies, we quantified and compared
Chit1 and AMCase expression levels in mouse and human
tissues [40,41]. Here, we applied our methodology to the
CLPs’ levels analysis. There was a concern that the
primers for Ym1 and Ym2 could cross-react with each
other because the nucleotide sequences of Ym1 and Ym2
are very similar. However, our primers for Ym1 and Ym2
can discriminate and amplify corresponding cDNAs from
the mouse tissue cDNA mixture (Figure 4). The reverse
primers for Ym1 and Ym2 contain unique sequences at
their 3’ terminal regions, which strongly affect PCR effi-
ciency, while the forward primers are similar between the
Ym1 and Ym2 cDNAs (Additional file 1: Figure S4). Our
results indicate that either the forward or the reverse
primer can contain unique sequences for the specific
amplification of a target cDNA, even though the nucleo-
tide sequences are very similar between these cDNAs.
This notion can be applied to quantify molecules that are
very similar to each other, such as Ym1 and Ym2.
When we validated the mouse Refs/CLPs standard
DNA, multiple products were amplified from the mouse
Refs/CLPs standard DNA using the Ym2 primers. This
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between Ym1/AMCase and Ym2 (Figure 1C and E). In
general, when for designing primers for RT-PCR, intron
sequences are included in the target region to avoid ampli-
fying non-target products from the contaminating gen-
omic DNA [49]. Because mammalian introns are more
than approximately ~3 kbp long, in general, genomic se-
quences are difficult to be amplified by PCR compared to
target cDNA. Because the mouse Refs/CLPs standard
DNA was cloned into the pGEM-T Easy vector (approxi-
mately ~3 kbp long, Figure 2A), we prepared a linearized
mouse Refs/CLPs standard DNA with pGEM-T Easy
sequence between Ym1 and Ym2 using PCR (Figure 2A
and B). Additionally, we changed our qPCR protocol
(annealing, 30 sec at 55°C; extension, 10 sec at 72°C). As a
result, we overcame the problems, and through the valid-
ation of the mouse Refs/CLPs standard DNA with pGEM-
T Easy, we could individually quantify Ym1 and Ym2
using the standard DNA (Figure 5).
Our results for the gene expression pattern of BRP-39,
Ym1 and Ym2 were essentially consistent with previous
reports [3,9,37]. Additionally, our analysis was suffi-
ciently sensitive to detect the CLPs and to provide a
comprehensive survey of the gene expression patterns of
the CLPs and reference genes using the same scale in
mouse tissues. The order of mRNA levels in mouse lung
tissues were as follows: GAPDH ≈ BRP-39 ≈ Ym1 >
AMCase > Chit1 > Ym2.
We found that BRP-39 and Ym1 mRNA displayed
similar expression patterns (Figure 6A and B). Ym1
mRNA was expressed at high levels in mouse lung,
whereas Ym2 mRNA was detected in stomach, followed
by lung. Although Ym1 and Ym2 show high sequence
homology, there is differential expression between them.
A detailed characterization of the promoter regions of
the CLPs genes and the identification of the cis- and
trans-acting factors will be required to understand the
selective gene expression of these CLPs in mice.
In mouse lung tissues, we found that the mRNA levels
of BRP-39 and Ym1 were higher than Chit1 and AMCase,
which are active chitinases. The levels of BRP-39 and Ym1
mRNA were comparable to those of GAPDH, a typical
constitutive gene. In the lungs, Chit1 and AMCase can act
as part of the host defense system to protect against
chitin-containing pathogens, such as fungi and mites
[50,54]. Compared with active chitinases, BRP-39 and
Ym1 are highly expressed in the mouse lung. In addition,
BRP-39 and Ym1 seem to be co-expressed in mouse lung
(Figure 6A and B). Qureshi et al. reported that BRP-39,
Ym1 and Ym2 are overexpressed in a model of
inflammation-promoted incipient neoplasia [55]. They
suggested that these CLPs may promote tissue remod-
eling and amplify immune responses [55]. Although
BRP-39 and Ym1 have been reported to lack detectablechitinolytic activity, the high levels of their expression
in mice suggest the physiological importance as bio-
logical defense in the mouse lung.
AMCase is predominantly overexpressed in the mouse
stomach [40,41], and a robust peak of activity was ob-
served at pH 2.0, suggesting that AMCase can function as
a digestive enzyme that breaks down chitin-containing
foods [23,56]. Chit1 is highly expressed (about 10-folds) in
stomach as compared to lung tissue (Figure 7). Because
Chit1 does not possess any chitinolytic activity at low gas-
tric pH 2 [21,57], it seems that Chit1 does not contribute
to chitinase activity in stomach. It has been shown that
Chit1 is produced at sites of near-neutral pH, such as the
non-glandular portion of the stomach and the small intes-
tine [53]. Thus, Chit1 may also function as a digestive en-
zyme that breaks down polymeric chitin under the neutral
tissue conditions such as small intestine.
Ym2 expression was lower than Chit1 and AMCase but
was much higher compared to BRP-39 and Ym1. The
function of Ym1 is not yet known, although surface plas-
mon resonance has demonstrated that Ym1 can bind to
chitobiose, chitotriose and chitotetraose; additionally, hep-
arin sulfate has also been suggested as a candidate ligand
[8]. Ym2 is also a CLP protein of unknown function that
is closely related to Ym1 [5]. The high expression of Ym2,
together with AMCase, may be involved in food process-
ing and defense mechanisms in the mouse stomach.
Increased levels of chitinase and CLP mRNAs and/or
proteins have been noted in many inflammatory conditions
[2,17,25]. The level of Chit1 is elevated in Gaucher disease,
in smokers and in patients with chronic obstructive
pulmonary disease (COPD) and Alzheimer disease [20,52,
58,59]. AMCase expression and activity are also up-
regulated during allergic airway responses in mouse models
of asthma and by polymeric chitin administration [50,51].
Thus, chitinases and CLPs may play important roles in
many pathophysiological conditions [2,38,39]. However, the
contribution of chitinases and CLPs to the pathophysiology
of these diseases remains to be determined.
In many studies on CLPs expression, the relative quan-
tification using qPCR or Western blotting have been
used for evaluation of CLPs levels [17,51,55,60]. Both
methods involve the normalization of the expression
levels of the gene of interest with those of the house-
keeping genes such as GAPDH or β-actin. The relative
quantification is easier to perform than the absolute
quantification as the mRNA levels of the gene of interest
are compared to the housekeeping genes. However, rela-
tive quantification methods fail to compare the levels of
the different gene transcripts on the same scale. Al-
though our method requires multiple steps associated
with the construction of the standard DNA, it can pro-
vide gene expression data that are directly comparable
between different genes.
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levels of BRP-39/YKL-40 in diseased mouse and human
lungs might be the result of expression deregulation
[2,38]. Furthermore, using BRP-39-deficient and YKL-40
transgenic mice, it was demonstrated that these proteins
are functionally equivalent and play roles in tissue remo-
deling, regulation of the cell death pathway and airway
obstruction [17]. Moreover, BRP-39 is induced during
bacterial infection, during which it promotes bacterial clear-
ance by controlling cell death, inflammation, and remodel-
ing via interleukin (IL)-13 receptor α2 [60,61]. Using the
quantification system described here, the CLPs mRNA
levels can be compared with mammalian chitinases across
mouse tissues using qPCR. This type of analysis can help to
understand the biological function of CLPs, particularly in
the pathophysiological studies using murine models.
Conclusions
We established and validated a qPCR system for individ-
ual quantification of the expression of three CLPs and
comparing their expression levels with those of reference
genes using the same scale in mouse tissues. We found
that BRP-39 was the most highly expressed CLP in the
mouse lung, and its expression was comparable to that
of GAPDH, a major housekeeping gene. Ym1 mRNA
was also expressed at a high level in the mouse lung,
whereas Ym2 mRNA was abundant in the stomach. Our
results indicate that catalytically inactive BRP-39 and
Ym1 are constitutively expressed in normal mouse lung.
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